WO2003075852A3 - Antibiotic composition - Google Patents

Antibiotic composition Download PDF

Info

Publication number
WO2003075852A3
WO2003075852A3 PCT/US2003/007118 US0307118W WO03075852A3 WO 2003075852 A3 WO2003075852 A3 WO 2003075852A3 US 0307118 W US0307118 W US 0307118W WO 03075852 A3 WO03075852 A3 WO 03075852A3
Authority
WO
WIPO (PCT)
Prior art keywords
antibiotic composition
antibiotic
products
different
different antibiotics
Prior art date
Application number
PCT/US2003/007118
Other languages
French (fr)
Other versions
WO2003075852A2 (en
Inventor
James D Isbister
Edward M Rudnic
Jr Donald J Treacy
Sandra E Wassink
Original Assignee
Advancis Pharmaceuticals Corp
James D Isbister
Edward M Rudnic
Jr Donald J Treacy
Sandra E Wassink
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/093,321 priority Critical patent/US6610328B2/en
Priority to US10/092,858 priority
Priority to US10/093,214 priority
Priority to US10/092,858 priority patent/US6632453B2/en
Priority to US10/093,321 priority
Priority to US10/092,854 priority patent/US6627222B2/en
Priority to US10/092,811 priority
Priority to US10/092,854 priority
Priority to US10/093,214 priority patent/US6638532B2/en
Priority to US10/092,811 priority patent/US6623758B2/en
Application filed by Advancis Pharmaceuticals Corp, James D Isbister, Edward M Rudnic, Jr Donald J Treacy, Sandra E Wassink filed Critical Advancis Pharmaceuticals Corp
Priority claimed from AU2003218024A external-priority patent/AU2003218024C1/en
Publication of WO2003075852A2 publication Critical patent/WO2003075852A2/en
Publication of WO2003075852A3 publication Critical patent/WO2003075852A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Abstract

Antibiotic products for delivering at least two different antibiotics, wherein the products are comprised of at least three or four dosage forms with different release profiles and the at least two different antibiotics are selected from specified antibiotic pairs.
PCT/US2003/007118 2000-02-24 2003-03-07 Antibiotic composition WO2003075852A2 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
US10/092,858 2002-03-07
US10/093,214 2002-03-07
US10/092,858 US6632453B2 (en) 2000-02-24 2002-03-07 Ciprofoxacin-metronidazole antibiotic composition
US10/093,321 2002-03-07
US10/092,854 US6627222B2 (en) 2000-02-24 2002-03-07 Amoxicillin-dicloxacillin antibiotic composition
US10/092,811 2002-03-07
US10/092,854 2002-03-07
US10/093,214 US6638532B2 (en) 2000-02-24 2002-03-07 Tetracycline—doxycycline antibiotic composition
US10/092,811 US6623758B2 (en) 2000-02-24 2002-03-07 Cephalosporin-metronidazole antibiotic composition
US10/093,321 US6610328B2 (en) 2000-02-24 2002-03-07 Amoxicillin-clarithromycin antibiotic composition

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03714005A EP1487414A4 (en) 2002-03-07 2003-03-07 Antibiotic composition
AU2003218024A AU2003218024C1 (en) 2002-03-07 2003-03-07 Antibiotic composition
JP2003574128A JP2005526059A (en) 2002-03-07 2003-03-07 Antibiotic compositions
CA 2478121 CA2478121A1 (en) 2002-03-07 2003-03-07 Antibiotic composition

Publications (2)

Publication Number Publication Date
WO2003075852A2 WO2003075852A2 (en) 2003-09-18
WO2003075852A3 true WO2003075852A3 (en) 2004-07-15

Family

ID=27808882

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/007118 WO2003075852A2 (en) 2000-02-24 2003-03-07 Antibiotic composition

Country Status (4)

Country Link
EP (1) EP1487414A4 (en)
JP (1) JP2005526059A (en)
CA (1) CA2478121A1 (en)
WO (1) WO2003075852A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889187B2 (en) 2000-02-24 2014-11-18 Shionogi Inc. Once a day amoxicillin product comprising immediate and delayed release dosage forms

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
AUPS167602A0 (en) * 2002-04-12 2002-05-16 F.H. Faulding & Co. Limited An improved modified release preparation
EP1771158A4 (en) * 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp Tablet for pulsed delivery
CA2602268A1 (en) * 2005-04-12 2006-10-19 Elan Pharma International Limited Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
BRPI0610683A2 (en) 2005-05-18 2010-07-20 Da Volterra applying absorbent colÈnica
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
WO2009137672A1 (en) * 2008-05-07 2009-11-12 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
US5001692A (en) * 1987-04-21 1991-03-19 U.S. Philips Corporation Optical recording system providing a recording signal waveform adapted to the recording characteristics of the record carrier, and recording apparatus and record carrier for use in such systems

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6232166B2 (en) * 1983-06-15 1987-07-13 Shionogi & Co
JPS61210025A (en) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk Stabilized antibioitc complex granule preparation
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
JPS63162619A (en) * 1986-12-25 1988-07-06 Teisan Seiyaku Kk Delayed soluble granule and sustained release complex granule using said granule
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
EP0804174A4 (en) * 1993-07-21 1998-09-09 Univ Kentucky Res Found A multicompartment hard capsule with control release properties
DE19718012C1 (en) * 1997-04-29 1998-10-08 Jenapharm Gmbh A process for the preparation of perorally administered solid drug with controlled effective ingredient delivery
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
AUPP437698A0 (en) * 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
US6384081B2 (en) * 1998-10-09 2002-05-07 Charles L. Berman Treatment of diseases of the eye characterized by the formation of metalloproteinase
EP1267765A4 (en) * 2000-02-24 2008-12-24 Middlebrook Pharmaceuticals In Antibiotic and antifungal compositions
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) * 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
US5001692A (en) * 1987-04-21 1991-03-19 U.S. Philips Corporation Optical recording system providing a recording signal waveform adapted to the recording characteristics of the record carrier, and recording apparatus and record carrier for use in such systems

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1487414A4 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889187B2 (en) 2000-02-24 2014-11-18 Shionogi Inc. Once a day amoxicillin product comprising immediate and delayed release dosage forms

Also Published As

Publication number Publication date
WO2003075852A2 (en) 2003-09-18
JP2005526059A (en) 2005-09-02
EP1487414A4 (en) 2007-12-12
CA2478121A1 (en) 2003-09-18
AU2003218024A1 (en) 2003-09-22
EP1487414A2 (en) 2004-12-22
AU2003218024B2 (en) 2008-09-11

Similar Documents

Publication Publication Date Title
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
TWI293293B (en) Novel pyrimidinone compounds, the preparation process thereof and pharmaceutical compositions comprising them
WO2003048081A3 (en) Glycinamides as factor xa inhibitors
HK1175046A1 (en) Dual-mode shared ofdm methods/transmitters, receivers and systems ofdm /
HK1080497A1 (en) Carbohydrate-modified polymers, compositions and uses related thereto
AU2002368033A1 (en) Wall construction and component for the same
AU2003210069A1 (en) Articles prepared from controlled distribution block copolymers
AU2977200A (en) Abrasive grain, abrasive articles, and methods of making and using the same
WO1999054286A3 (en) Btk inhibitors and methods for their identification and use
PL376154A1 (en) Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
AU2002359376A1 (en) N, N'-substituted-1,3-diamino-2-hydroxypropane derivatives
SI1673352T1 (en) Sulfoximine-substituted pyrimidines for use as cd and/or vegf-inhibitors, the production thereof and their use as drugs
EP1852437A3 (en) 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
AU2007301A (en) Solid mixture consisting of foodstuff ingredients and foodstuff additives, method for the production thereof, and their use
AU2003233010A1 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
HK1043591A1 (en) Substituted 2-aryl-3-(heteroaryl)-imidazo Ä1,2-alphaÜpyrimidines, and related pharmaceutical compositions and methods
HK1042486A1 (en) Novel amidine derivatives, their preparation and application as menicines and pharmaceutical compositions containing same.
HK1045650A1 (en) Pharmaceutical composition.
AU2003269813A1 (en) Gradient structures interfacing microfluidics and nanofluidics, methods for fabrication and uses thereof
WO2005023761A3 (en) Cytokine inhibitors
IL164764A (en) Factor vii or viia polypeptide variants, pharmaceutical compositions comprising the same, method for their preparation and uses thereof
AU4477001A (en) Injectable sustained release pharmaceutical composition and processes for preparing the same
AU2002242024A1 (en) Pharmaceutical formulation
AU2002341881A1 (en) 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
IL165715A (en) 2-ureido-6-heteroaryl-3h-benzimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2478121

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003218024

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2003574128

Country of ref document: JP

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003714005

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003714005

Country of ref document: EP